Economic TimesLean R·
Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?
ET Intelligence Group: Molbio Diagnostics, a molecular diagnostics manufacturer, plans to raise ₹200 crore through a fresh issue for capital expenditure. It will also raise ₹740 crore through an offer for sale. The promoter group's stake will fall to 43% after the IPO from 46.6%. The company operates six manufacturing facilities across India and serves customers in over 90 countries, including government health programmes, diagnostic laboratories, hospitals, and international healthcare organis…
Read at Economic Times →
